Recently, it was shown that, in patients with severe coronavirus disease 2019 (COVID-19), plasma PAI-1 levels were as highly elevated as compared to patients with bacterial sepsis or ARDS [88]. This evidence concerns the gene SERPINE1 and acute respiratory distress syndrome.